60 Results (Page 1 of 5)
Pharmaceuticals Free Markets Research Reports
India Acne Drugs Market Analysis Sample Report
This report presents a strategic analysis of the India Acne Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the India Acne Drugs Market, offering unmatched value, accuracy and expert insights.
New Zealand Retail Pharmacy Market Analysis Sample Report
This report presents a strategic analysis of the New Zealand Retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the New Zealand Retail Pharmacy Market, offering unmatched value, accuracy and expert insights.
Algeria Retail Pharmacy Market Analysis Sample Report
This report presents a strategic analysis of the Algeria Retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Algeria Retail Pharmacy Market, offering unmatched value, accuracy and expert insights.
Australia Retail Pharmacy Market Analysis Sample Report
The Australia Retail Pharmacy Market is projected to grow from $12.46 Bn in 2022 to $23.76 Bn by 2030, registering a CAGR of 8.4% during the forecast period of 2022 - 2030. It is anticipated that the Prescription Drugs segment would continue to hold the largest share during the forecast period. Chemist Warehouse is one of the largest retail pharmacy chains in Australia, with over 400 stores across the country. It is known for offering a wide range of products at competitive prices.
Canada Dermatology Prescription Market Analysis Sample Report
Canada's dermatology prescription market is expected to grow from $459.7 Mn in 2022 to $927.4 Mn in 2030 with a CAGR of 9.2% for the year 2022-30. Rising incidences of dermatology disorders involving the skin, nails, hair, etc, and the demand for novel therapeutics for the treatment of dermatology disorders in Canada are major market drivers of the Canadian dermatology prescription market. the market is segmented by disease type, drug class, route of administration, end-user, and by distribution channel. Affinium, Pfizer, and Sanofi are some of the key players in Canada's dermatology prescription market.
Italy Oral care market Analysis Sample Report
Italy's Oral Care market was valued at $846 Mn in 2022 and is estimated to expand at a CAGR of 5.7% from 2022 to 2030 and will reach $1317 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of Increasing Demand for Natural and Organic Products, the ageing population. The market is segmented by type, drug and distribution channel. Some key players in this market are 3M, A-Dec Inc., Biolase Inc., Carestream Health Inc., Dentsply Sirona, and Envista Holdings Corporation among others.
Vietnam Cancer Immunotherapy Market Analysis Sample Report
Vietnam's cancer immunotherapy market is expected to grow from $563 Mn in 2022 to $991 Mn in 2030 with a CAGR of 7.3% for the forecasted year 2022-30. The rise in the prevalence of cancer and the increasing health expenditures in Vietnam are driving the growth of the market. The Vietnam cancer immunotherapy market is segmented by type, application, and end user. Imexpharm, Binh Dinh Pharmaceuticals, and Amgen are the major players in the Vietnam cancer immunotherapy market.
Australia Oral Care Market Analysis Sample Report
Australia's Oral Care market was valued at $423 Mn in 2022 and is estimated to expand at a CAGR of 7.7% from 2022 to 2030 and will reach $765 Mn in 2030. One of the main reasons propelling the growth of this market is Increasing Disposable Income and the ageing population. The market is segmented by type, drug, and distribution channel. Some key players in this market are White Glo, Grants of Australia, Red Seal, Dr. Brite, and Pure Smile among others.
Brazil Oncology Drugs Market Analysis Sample Report
By 2030, it is anticipated that the Brazil oncology drugs market will reach a value of $12.7 Bn from $4.9 Bn in 2022, growing at a CAGR of 12.6% during 2022-2030. The oncology drug market in Brazil is dominated by a few large pharmaceutical companies such as EMS Pharma, Eurofarma, and Takeda Pharma. The oncology market in Brazil is segmented by different therapeutic areas and by different treatment types. The major factors affecting the Brazilian oncology drugs market are the high cost of the drugs, and the structured reimbursement system for the treatment.
Canada Retail Pharmacy Market Analysis Sample Report
This report presents a strategic analysis of the Canada Retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Canada Retail Pharmacy Market, offering unmatched value, accuracy and expert insights.
UAE Oncology Drugs Market Analysis Sample Report
By 2030, it is anticipated that the UAE oncology drugs market will reach a value of $2.54 Bn from $0.98 Bn in 2022, growing at a CAGR of 12.6% during 2022-2030. The oncology drug market in UAE is dominated by a few large pharmaceutical companies such as Biopharma Middle East & Africa, Neopharma Pharmaceutical Plant, and Newbridge Pharmaceuticals FZ LLC. The oncology market in UAE is segmented by different therapeutic areas, into breast cancer, lung cancer, colorectal cancer, prostate cancer, and others. The market is also segmented based on treatment types, such as surgery, radiation therapy, chemotherapy, and targeted therapy.
Middle East Alzheimer’s Disease Drugs Market Analysis Sample Report
Middle East Alzheimer’s Disease Drugs market was valued at $617 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.42% from 2022 to 2030 and will reach $1267 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and government initiatives. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are Johnson and Johnson, Lupin Limited, Biogen Inc, Pfizer Inc, F. Hoffmann-La Roche AG, Novartis AG, Allergan Plc (acquired by Abbvie), Amarantus Bioscience Holdings Inc, and GE Healthcare.